相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。11q deletion in neuroblastoma: a review of biological and clinical implications
Vid Mlakar et al.
MOLECULAR CANCER (2017)
Transcription instability in high-risk neuroblastoma is associated with a global perturbation of chromatin domains
Carlo Zanon et al.
MOLECULAR ONCOLOGY (2017)
Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis?
Gian Paolo Tonini
BMC CANCER (2017)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
R. Defferrari et al.
BRITISH JOURNAL OF CANCER (2015)
An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era
Zhenqiang Su et al.
GENOME BIOLOGY (2014)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
H. Kocak et al.
CELL DEATH & DISEASE (2013)
Neuroblastoma and MYCN
Miller Huang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
G. Schleiermacher et al.
BRITISH JOURNAL OF CANCER (2012)
Chromosomal instability and cancer: a complex relationship with therapeutic potential
Samuel F. Bakhoum et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
Linda J. Valentijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients
A. Oberthuer et al.
PHARMACOGENOMICS JOURNAL (2010)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics
Jo Vandesompele et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
Scott L. Carter et al.
NATURE GENETICS (2006)
Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma
R Spitz et al.
CLINICAL CANCER RESEARCH (2006)
Chromosome 1p and 11q deletions and outcome in neuroblastoma
EF Attiyeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group
WB London et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma
PS White et al.
ONCOGENE (2005)
Neuroblastoma: biology and molecular and chromosomal pathology
M Schwab et al.
LANCET ONCOLOGY (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Fluorescence in situ hybridization analyses of chromosome band I p36 in neuroblastoma detect two classes of alterations
R Spitz et al.
GENES CHROMOSOMES & CANCER (2002)
Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis
MEMO Luttikhuis et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
